SUBSCRIBE
SUBSCRIBE
News   Drug Development

Onyx Pharmaceuticals, Inc. Says FDA Agrees on Blood Cancer Drug Trial Design

February 2, 2010 | 
1 min read
Reuters -- Onyx Pharmaceuticals Inc said it reached an agreement with the U.S. Food and Drug Administration on the design of the late-stage trial of its blood cancer drug.
Clinical research Phase III
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Contemporary art collage of human hands holding a arrow pointing up, graphs and diagrams. Concept of profit, making money, business. Copy space.
Cardiovascular disease
Ionis’ Tryngolza Hits ‘Best-Case Scenario’ in Late-Stage Triglyceride Study
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Modern collage with human heart and hands stock illustration
Cardiovascular disease
Cytokinetics Soars on Aficamten’s ‘Best-in-Class’ Performance in Phase III Cardio Study
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
CDC Faces Critical Meetings Amid COVID Vaccine Uncertainty, Plus Deals, FDA Approvals, More
September 3, 2025
 · 
1 min read
 · 
Jef Akst
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie